Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Alnylam Pharmaceuticals, Inc.

ALNY Technical Analysis Summary (NASDAQ)

Analyze ALNY on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.

ALNY●NASDAQ
HealthcareBiotechnology
$228.06
$7.73(3.51%)
U.S. Market is Open · 15:28

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

ALNY Technical Analysis Summary (NASDAQ)

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stock currently shows a bearish trend on the NASDAQ, supported by momentum and weak buying pressure.

Overall Sentiment:Sell
Momentum:Bearish to Weak (RSI: 30.63)
Trend Strength:Moderate (ADX: 26.83)
Volatility:High (ATR: 16.30)
Support/Resistance:$205.43 – $333.38 (Bollinger Bands)

Technical conditions suggest Alnylam Pharmaceuticals, Inc. on the NASDAQ is awaiting a decisive move. Technical conditions suggest Alnylam Pharmaceuticals, Inc. is consolidating, awaiting a decisive move.

Momentum Indicators

RSI (14): 30.63

Bearish
Below midpoint indicates downward pressure.

Stochastic %K: 18.00

Bullish
Oversold zone signals rebound potential.

Williams %R: -78.59

Bearish
Sellers maintain momentum below neutral.

Rate of Change (ROC): -22.02

Strongly Bearish
Sharp downside momentum.

Takeaway:Alnylam Pharmaceuticals, Inc. shows weakening momentum, with sellers gaining the edge.

Trend & Volatility

MACD: -18.34

Bearish
Bearish, trend momentum is strengthening to the downside.

ADX: 26.83

Moderate
Moderate trend, direction gaining strength.

ATR (14): 16.30

Rising
Rising volatility, market activity increasing.

CCI (14): -101.52

Bearish
Bearish, oversold conditions may spark rebound.

Takeaway:Alnylam Pharmaceuticals, Inc. shows oversold trend conditions, with potential for rebound if buyers step in.

Support & Resistance indicators
Bollinger Bands
Upper Band
$333.38
Middle Band (SMA 20)
$269.41
Lower Band
$205.43
Current Position
Within Bands

Takeaway:Alnylam Pharmaceuticals, Inc. trades closer to support, showing weaker momentum within bands.

Keltner Channels
Upper Channel
$293.25
Middle Line (EMA 20)
$260.66
Lower Channel
$228.06
Squeeze Status
No Squeeze

Takeaway:Alnylam Pharmaceuticals, Inc. trades below the trend line, showing weaker momentum inside the channel.

Volume & Money Flow Analysis
On-Balance Volume-14.09M
Money Flow Index43.87Neutral, balanced money flows with no clear signal.
Relative Vigor Index50.04Neutral to Bullish, buyers hold a slight edge.

Overall Takeaway:ALNY shows neutral money flow, with no clear directional pressure.

Technical Trading Signals Summary
Based on the current technical analysis of Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), here are the key trading signals and recommendations:

Bullish Signals

ADX above 20 → strong underlying trend.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

MACD below signal line → short-term caution on momentum.

Overall Recommendation:Alnylam Pharmaceuticals, Inc. shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.

(NASDAQ: ALNY) Technical Analysis FAQ